Health
SARS-CoV-2 pneumonia and bacterial pneumonia patients differ in a second hit immune response model
Delano, M. J. & Ward, P. A. The immune system’s role in sepsis progression, resolution, and long-term outcome. Immunol. Rev. 274, 330–353. https://doi.org/10.1111/imr.12499 (2016).
van Vught, L. A. et al. Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA 315, 1469–1479. https://doi.org/10.1001/jama.2016.2691 (2016).
Jia, L. et al. Mechanisms of severe mortality-associated bacterial co-infections following influenza virus infection. Front. Cell. Infect. Microbiol. 7, 338. https://doi.org/10.3389/fcimb.2017.00338 (2017).
Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506. https://doi.org/10.1016/s0140-6736(20)30183-5 (2020).
Gao, Y. M., Xu, G., Wang, B. & Liu, B. C. Cytokine storm syndrome in coronavirus disease 2019: A narrative review. J. Intern. Med. 289, 147–161. https://doi.org/10.1111/joim.13144 (2021).
Ragab, D., Salah Eldin, H., Taeimah, M., Khattab, R. & Salem, R. The COVID-19 cytokine storm; What we know so far. Front. Immunol. 11, 1446. https://doi.org/10.3389/fimmu.2020.01446 (2020).
Hu, B., Huang, S. & Yin, L. The cytokine storm and COVID-19. J. Med. Virol. 93, 250–256. https://doi.org/10.1002/jmv.26232 (2021).
Chen, G. et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Investig. 130, 2620–2629. https://doi.org/10.1172/jci137244 (2020).
Moser, D. et al. COVID-19 impairs immune response to Candida albicans. Front. Immunol. 12, 640644. https://doi.org/10.3389/fimmu.2021.640644 (2021).
Feuerecker, M. et al. Early immune anergy towards recall antigens and mitogens in patients at onset of septic shock. Sci. Rep. 8, 1754. https://doi.org/10.1038/s41598-018-19976-w (2018).
Chakraborty, R. K. & Burns, B. StatPearls (StatPearls Publishing Copyright © 2021 (StatPearls Publishing LLC, 2021).
Assinger, A., Schrottmaier, W. C., Salzmann, M. & Rayes, J. Platelets in sepsis: An update on models and clinical data. Front. Immunol. 10, 1687. https://doi.org/10.3389/fimmu.2019.01687 (2019).
Unsinger, J. et al. Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis. J. Infect. Dis. 206, 606–616. https://doi.org/10.1093/infdis/jis383 (2012).
Hamers, L., Kox, M. & Pickkers, P. Sepsis-induced immunoparalysis: Mechanisms, markers, and treatment options. Minerva Anestesiol. 81, 426–439 (2015).
Wilson, J. G. et al. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis. JCI Insight https://doi.org/10.1172/jci.insight.140289 (2020).
Knight, S. R. et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: Development and validation of the 4C Mortality Score. BMJ 370, m3339. https://doi.org/10.1136/bmj.m3339 (2020).
Otsuka, R. & Seino, K. I. Macrophage activation syndrome and COVID-19. Inflamm. Regener. 40, 19. https://doi.org/10.1186/s41232-020-00131-w (2020).
Fajgenbaum, D. C. & June, C. H. Cytokine storm. N. Engl. J. Med. 383, 2255–2273. https://doi.org/10.1056/NEJMra2026131 (2020).
Hotchkiss, R. S., Monneret, G. & Payen, D. Immunosuppression in sepsis: A novel understanding of the disorder and a new therapeutic approach. Lancet Infect. Dis. 13, 260–268. https://doi.org/10.1016/s1473-3099(13)70001-x (2013).
Rimmelé, T. et al. Immune cell phenotype and function in sepsis. Shock 45, 282–291. https://doi.org/10.1097/shk.0000000000000495 (2016).
McGonagle, D., Sharif, K., O’Regan, A. & Bridgewood, C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun. Rev. 19, 102537. https://doi.org/10.1016/j.autrev.2020.102537 (2020).
Cicco, S., Cicco, G., Racanelli, V. & Vacca, A. Neutrophil extracellular traps (NETs) and damage-associated molecular patterns (DAMPs): Two potential targets for COVID-19 treatment. Mediat. Inflamm. 2020, 7527953. https://doi.org/10.1155/2020/7527953 (2020).
Mishra, K. P., Singh, A. K. & Singh, S. B. Hyperinflammation and immune response generation in COVID-19. NeuroImmunoModulation 27, 80–86. https://doi.org/10.1159/000513198 (2020).
Tolle, L. B. & Standiford, T. J. Danger-associated molecular patterns (DAMPs) in acute lung injury. J. Pathol. 229, 145–156. https://doi.org/10.1002/path.4124 (2013).
Jimeno, S. et al. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19. Eur. J. Clin. Invest. 51, e13404. https://doi.org/10.1111/eci.13404 (2021).
Li, X. et al. Effect of combination antiviral therapy on hematological profiles in 151 adults hospitalized with severe coronavirus disease 2019. Pharmacol. Res. 160, 105036. https://doi.org/10.1016/j.phrs.2020.105036 (2020).
Han, H. et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg. Microb. Infect. 9, 1123–1130. https://doi.org/10.1080/22221751.2020.1770129 (2020).
De Biasi, S. et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat. Commun. 11, 3434. https://doi.org/10.1038/s41467-020-17292-4 (2020).
Trouillet-Assant, S. et al. Type I IFN immunoprofiling in COVID-19 patients. J. Allergy Clin. Immunol. 146, 206-208.e202. https://doi.org/10.1016/j.jaci.2020.04.029 (2020).
Chowdhury, M. A., Hossain, N., Kashem, M. A., Shahid, M. A. & Alam, A. Immune response in COVID-19: A review. J. Infect. Public Health 13, 1619–1629. https://doi.org/10.1016/j.jiph.2020.07.001 (2020).
Mehta, P. et al. Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: Challenges and opportunities. Lancet Respir. Med. 8, 822–830. https://doi.org/10.1016/s2213-2600(20)30267-8 (2020).
Remy, K. E. et al. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections. JCI Insight https://doi.org/10.1172/jci.insight.140329 (2020).
Langford, B. J. et al. Bacterial co-infection and secondary infection in patients with COVID-19: A living rapid review and meta-analysis. Clin. Microbiol. Infect. 26, 1622–1629. https://doi.org/10.1016/j.cmi.2020.07.016 (2020).
Wu, C. P., Adhi, F. & Highland, K. Recognition and management of respiratory co-infection and secondary bacterial pneumonia in patients with COVID-19. Clevel. Clin. J. Med. 87, 659–663. https://doi.org/10.3949/ccjm.87a.ccc015 (2020).
Rawson, T. M. et al. Bacterial and fungal coinfection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin. Microbiol. Infect. 71, 2459–2468. https://doi.org/10.1093/cid/ciaa530 (2020).
Garcia-Vidal, C. et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: A retrospective cohort study. Clin. Microbiol. Infect. 27, 83–88. https://doi.org/10.1016/j.cmi.2020.07.041 (2021).
Fekkar, A. et al. Occurrence of invasive pulmonary fungal infections in patients with severe COVID-19 admitted to the ICU. Am. J. Respir. Crit. Care Med. 203, 307–317. https://doi.org/10.1164/rccm.202009-3400OC (2021).
Maes, M. et al. Ventilator-associated pneumonia in critically ill patients with COVID-19. Crit. Care https://doi.org/10.1186/s13054-021-03460-5 (2021).
Pickens, C. O. et al. Bacterial superinfection pneumonia in patients mechanically ventilated for COVID-19 pneumonia. Am. J. Respir. Crit. Care Med. 204, 921–932. https://doi.org/10.1164/rccm.202106-1354OC (2021).
Rouzé, A. et al. Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: A European multicenter cohort study. Intens. Care Med. 47, 188–198. https://doi.org/10.1007/s00134-020-06323-9 (2021).
Grasselli, G. et al. Hospital-acquired infections in critically Ill patients With COVID-19. Chest 160, 454–465. https://doi.org/10.1016/j.chest.2021.04.002 (2021).
Rawson, T. M., Wilson, R. C. & Holmes, A. Understanding the role of bacterial and fungal infection in COVID-19. Clin. Microbiol. Infect. 27, 9–11. https://doi.org/10.1016/j.cmi.2020.09.025 (2021).
Zhang, J. et al. Secondary bloodstream infection in critically ill patients with COVID-19. J. Int. Med. Res. 49, 3000605211062783. https://doi.org/10.1177/03000605211062783 (2021).
Copin, M. C., Parmentier, E., Duburcq, T., Poissy, J. & Mathieu, D. Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection. Intens. Care Med. 46, 1124–1126. https://doi.org/10.1007/s00134-020-06057-8 (2020).
Ackermann, M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 383, 120–128. https://doi.org/10.1056/NEJMoa2015432 (2020).
Arastehfar, A. et al. COVID-19 associated pulmonary aspergillosis (CAPA)-from immunology to treatment. J. Fungi 6, 91. https://doi.org/10.3390/jof6020091 (2020).
Koehler, P. et al. COVID-19 associated pulmonary aspergillosis. Mycoses 63, 528–534. https://doi.org/10.1111/myc.13096 (2020).
Lai, C. C. & Yu, W. L. COVID-19 associated with pulmonary aspergillosis: A literature review. J. Microbiol. Immunol. Infect. 54, 46–53. https://doi.org/10.1016/j.jmii.2020.09.004 (2021).
Otto, G. P. et al. The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit. Care 15, R183. https://doi.org/10.1186/cc10332 (2011).
Zhuang, Y., Peng, H., Chen, Y., Zhou, S. & Chen, Y. Dynamic monitoring of monocyte HLA-DR expression for the diagnosis, prognosis, and prediction of sepsis. Front. Biosci. 22, 1344–1354. https://doi.org/10.2741/4547 (2017).
Pandey, K., Malviya, D., Awasthi, N. P., Nathi, S. S. & Harjai, M. Comparison of neutrophil CD64 and monocytic HLA-DR with existing biomarkers for the diagnosis and prognosis of sepsis. Anaesthesiol. Intens. Therapy 53, 304–311. https://doi.org/10.5114/ait.2021.108579 (2021).
Bonnet, B. et al. Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation. EBioMedicine 73, 103622. https://doi.org/10.1016/j.ebiom.2021.103622 (2021).
Wilk, A. J. et al. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19. J. Exp. Med. https://doi.org/10.1084/jem.20210582 (2021).
Bloos, F. et al. Effect of sodium selenite administration and procalcitonin-guided therapy on mortality in patients with severe sepsis or septic shock: A randomized clinical trial. JAMA Intern. Med. 176, 1266–1276. https://doi.org/10.1001/jamainternmed.2016.2514 (2016).
Bekeredjian-Ding, I., Foermer, S., Kirschning, C. J., Parcina, M. & Heeg, K. Poke weed mitogen requires Toll-like receptor ligands for proliferative activity in human and murine B lymphocytes. PLoS ONE 7, e29806. https://doi.org/10.1371/journal.pone.0029806 (2012).
|
Sources 2/ https://www.nature.com/articles/s41598-022-17368-9 The mention sources can contact us to remove/changing this article |
What Are The Main Benefits Of Comparing Car Insurance Quotes Online
LOS ANGELES, CA / ACCESSWIRE / June 24, 2020, / Compare-autoinsurance.Org has launched a new blog post that presents the main benefits of comparing multiple car insurance quotes. For more info and free online quotes, please visit https://compare-autoinsurance.Org/the-advantages-of-comparing-prices-with-car-insurance-quotes-online/ The modern society has numerous technological advantages. One important advantage is the speed at which information is sent and received. With the help of the internet, the shopping habits of many persons have drastically changed. The car insurance industry hasn't remained untouched by these changes. On the internet, drivers can compare insurance prices and find out which sellers have the best offers. View photos The advantages of comparing online car insurance quotes are the following: Online quotes can be obtained from anywhere and at any time. Unlike physical insurance agencies, websites don't have a specific schedule and they are available at any time. Drivers that have busy working schedules, can compare quotes from anywhere and at any time, even at midnight. Multiple choices. Almost all insurance providers, no matter if they are well-known brands or just local insurers, have an online presence. Online quotes will allow policyholders the chance to discover multiple insurance companies and check their prices. Drivers are no longer required to get quotes from just a few known insurance companies. Also, local and regional insurers can provide lower insurance rates for the same services. Accurate insurance estimates. Online quotes can only be accurate if the customers provide accurate and real info about their car models and driving history. Lying about past driving incidents can make the price estimates to be lower, but when dealing with an insurance company lying to them is useless. Usually, insurance companies will do research about a potential customer before granting him coverage. Online quotes can be sorted easily. Although drivers are recommended to not choose a policy just based on its price, drivers can easily sort quotes by insurance price. Using brokerage websites will allow drivers to get quotes from multiple insurers, thus making the comparison faster and easier. For additional info, money-saving tips, and free car insurance quotes, visit https://compare-autoinsurance.Org/ Compare-autoinsurance.Org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc. "Online quotes can easily help drivers obtain better car insurance deals. All they have to do is to complete an online form with accurate and real info, then compare prices", said Russell Rabichev, Marketing Director of Internet Marketing Company. CONTACT: Company Name: Internet Marketing CompanyPerson for contact Name: Gurgu CPhone Number: (818) 359-3898Email: [email protected]: https://compare-autoinsurance.Org/ SOURCE: Compare-autoinsurance.Org View source version on accesswire.Com:https://www.Accesswire.Com/595055/What-Are-The-Main-Benefits-Of-Comparing-Car-Insurance-Quotes-Online View photos
to request, modification Contact us at Here or [email protected]
 |
 |
 |
